
Lisiena Hysenaj: Excited to Announce the Jeroen Roose Lab’s Latest Publication from Laila Karra Khalil
Lisiena Hysenaj, Translation Immunology Lead at Parvus Therapeutics Inc, shared on LinkedIn:
”Excited to announce the Jeroen Roose Lab’s latest publication from Laila Karra Khalil in Blood Journals Portfolio!
In this study, the team utilized single-cell proteomics to explore how changes in the Ras pathway influence hematopoiesis, highlighting variations in lineage bias, stem/progenitor cell maintenance, and cellular metabolism.
This project was a truly collaborative effort, involving diverse teams (Matt Spitzer, Alexis Combes) at University of California, San Francisco and significant contributions from Rafael J. Argüello at CIML in France.
I am grateful for the chance to work with such talented colleagues and to strengthen our partnerships with collaborators in France.”
Read the full article in Blood Advances.
Article: Single-cell proteomics characterization of bone marrow hematopoiesis with distinct Ras pathway lesions
Authors: Laila Karra, Anna-Marie Finger, Lauren Shechtman, Milana Krush, Rita Meng-Yao Huang, Morgan Prinz, Iliana Tennvooren, Kriti Bahl, Lisiena Hysenaj, Paulina G. Gonzalez, Alexis J. Combes, Hugo Gonzalez, Rafael J. Argüello, Matthew H. Spitzer, Jeroen P. Roose
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 7, 2025, 08:27John Chuback - Blood Clots: The Silent Killer
-
Oct 7, 2025, 04:20Nita Radhakrishnan to Present The First Indian Collaborative Data on Hemophilia from the WBDR Registry
-
Oct 6, 2025, 17:51Klaus Mönkemüller Just Released "The EndoCollab Guide for GI Bleeding" For Endoscopists
-
Oct 6, 2025, 08:10Haemophilia Foundation Australia: Animals Can Have Bleeding Disorders Too!
-
Oct 6, 2025, 08:03Peter Libby: Exploring Inflammation in Atherosclerosis: Lessons and Therapeutic Implications
-
Oct 7, 2025, 08:31Brooke Wolford Leads Groundbreaking GWAS Study Identifying Novel Genetic Loci for Venous Thromboembolism
-
Oct 7, 2025, 08:25ImmuneLink LLC Research: Role of Interferon-Gamma (IFN-γ) in Pathophysiology and Management of Deep Vein Thrombosis
-
Oct 7, 2025, 03:56Nathan Connell: Interesting Data in The Management of HAC Has Been Published in Blood from Benoit Guillet and Colleagues
-
Oct 7, 2025, 03:40Nature Communications Study by Amelia Haj and Colleagues Identifies Factor XII as a Safer Target for Anticoagulation
-
Oct 7, 2025, 03:36Lisiena Hysenaj: Excited to Announce the Jeroen Roose Lab’s Latest Publication from Laila Karra Khalil
-
Oct 7, 2025, 03:502025 Nobel Prize: A Milestone for Autoimmunity Research - Awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi
-
Oct 3, 2025, 15:31Anirban Sen Gupta and Andrew Shoffstall Collaboration on Bioinspired Synthetic Platelet Systems for Brain Injury Treatment
-
Oct 3, 2025, 15:07Shai Shen-Orr: Excited to Share that The Human Immunome Project (HIP) Has Launched Its Scientific Partner Network
-
Oct 2, 2025, 04:59Caterina Casari - Prizes for Innovators 2025 Winner!
-
Oct 2, 2025, 04:572025 Innovators Award: Ile de France Région Recognizes 3 Researchers Who Have Committed Themselves to The Innovation
-
Oct 7, 2025, 08:29“48 Poems on 48 Blood Group Systems” - Dr Bhavyaa Beriwal Blends Science and Poetry in Her New Transfusion Medicine Book
-
Oct 7, 2025, 04:35Hema Tallman: During IPAW, We Honor The Unseen Heroes – Plasma Donors
-
Oct 7, 2025, 04:09Svenja Tatjana Barckhausen: Reducing Reliance on U.S. Plasma – Not Just for Europe, But for The World!
-
Oct 7, 2025, 03:58Louise Bannon: Don’t Wait Until You’re Diagnosed to Learn About Blood Clots
-
Oct 6, 2025, 07:40Erin VanDyke: World Thrombosis Day Falls Right At The End Of PA Week, And It’s A Powerful Reminder Of Why I Do What I Do